Des Atouts Changement Date
Acadia Pharmaceuticals USD 1.61B 41.04M 2026-03
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
Amgen USD 92.5B 1.92B 2026-03
Ardelyx USD 504.51M 2.9M 2026-03
Astellas Pharma JPY 3.57T 36.87B 2026-03
AstraZeneca USD 115.83B 1.82B 2026-06
Bayer EUR 107.94B 3.4B 2026-03
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Celltrion KRW 768.81B 9.37B 2026-03
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Exelixis USD 2.59B 250.83M 2026-03
Fresenius Medical Care EUR 31.47B 465.26M 2026-03
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Ironwood Pharmaceuticals USD 434.57M 37.66M 2026-03
J&J USD 201.06B 167M 2026-06
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Moderna USD 10.96B 527M 2026-06
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 521.31M 9.36M 2026-03
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pharma Mar EUR 385.26M 9.82M 2026-03
Prothena USD 349.89M 23.09M 2026-03
PTC Therapeutics USD 3.25B 381.37M 2026-06
Qiagen NV USD 5.78B 513.9M 2026-03
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
Sartorius EUR 9.6B 270.6M 2026-06
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Tilray USD 2.1B 15.95M 2025-09
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03